Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. In March 2021, Item 9 Labs Corp. (OTCMKTS: INLB) entered a unique position to capitalize on opportunities in a rapidly evolving U.S. regulatory environment. The company combined its Item 9 Labs’ premium, award-winning products with the Unity Rd. dispensary franchise through the acquisition of OCG, Inc. Since then, Item 9 Labs Corp. has been making waves throughout the cannabis industry, achieving profitability for its 2nd quarter fiscal year 2021 and boasting now 7 consecutive quarters of revenue growth with its recent Q3 2021 earnings report. Led by a veteran-driven support team,…